1. O'Donnell MJ, Xavier D, Liu L et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112-23. doi:10.1016/S0140-6736(10)60834-3
2. Power A. Stroke in dialysis and chronic kidney disease. Blood Purif. 2013;36(3-4):179-83. doi: 10.1159/000356086
3. Shi Y, Wardlaw JM. Update on cerebral small vessel disease: a dynamicwhole-brain disease. Stroke Vasc Neurol. 2016 ;1(3):83-92. doi:10.1136/svn-2016-000035
4. Kuo CC, Lee CT, Ho SC, Kuo HW, Wu TN, Yang CY. Haemodialysis and the risk of stroke: A population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Nephrology. 2012;17(3):243-8. doi:10.1111/j.1440-1797.2011.01551.x.
5. Yao Q, Pecoits-Filho R, Lindholm B, Stenvinkel P. Traditional andnon-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease. Scand J Urol Nephrol. 2004;38(5):405-16.
6. Seliger SL, Gillen DL, Longstreth WT Jr, Kestenbaum B, Stehman-Breen CO.Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64(2):603-9.
7. Iseki K, Kinjo K, Kimura Y, Osawa A, Fukiyama K. Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int. 1993;44(5):1086-90.
8. Wang HH, Hung SY, Sung JM, Hung KY, Wang JD. Risk of stroke in long-termdialysis patients compared with the general population. Am J Kidney Dis. 2014;63(4):604-11. doi: 10.1053/j.ajkd.2013.10.013
9. Fu J, Huang J, Lei M, et al. Prevalence and Impact on Stroke in Patients Receiving Maintenance Hemodialysis versus Peritoneal Dialysis: A Prospective Observational Study. PLoS One. 2015;10(10):e0140887. doi: 10.1371/journal.pone.0140887. doi: 10.1371/journal.pone.0140887.
10. Power A, Chan K, Singh SK, Taube D, Duncan N. Appraising stroke risk inmaintenance hemodialysis patients: a large single-center cohort study. Am JKidney Dis. 2012;59(2):249-57. doi: 10.1053/j.ajkd.2011.07.016.
11. Iseki K, Fukiyama K; Okawa Dialysis Study (OKIDS) Group. Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. The Okinawa Dialysis Study (OKIDS) Group. Nephrol Dial Transplant. 2000;15(11):1808-13.
12. Walther CP, Carter CW, Low CL, et al. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis. Nephrol Dial Transplant. 2012;27(2):771-6. doi: 10.1093/ndt/gfr389
13. Kalantar-Zadeh K, Streja E, Molnar MZ, et al. Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using compositeranking score analysis. Am J Epidemiol. 2012;175(8):793-803. doi:10.1093/aje/kwr384
14. Moreau-Gaudry X, Guebre-Egziabher F, Jean G, et al. Serum creatinine improves body mass index survival prediction in hemodialysis patients: a 1-year prospective cohort analysis from the ARNOS study. J Ren Nutr. 2011;21(5):369-75. doi:10.1053/j.jrn.2010.08.005
15. Arase H, Yamada S, Yotsueda R, et al. Modified creatinine index and risk for cardiovascular events and all-cause mortality in patients undergoing hemodialysis: The Q-Cohort study. Atherosclerosis. 2018;275:115-123. doi:10.1016/j.atherosclerosis.2018.06.001
16. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation. 2005;112(6):900-5.
17. Elkind MS, Luna JM, McClure LA, et al. C-reactive protein as a prognostic marker after lacunar stroke:levels of inflammatory markers in the treatment of stroke study. Stroke. 2014 ;45(3):707-16. doi: 10.1161/STROKEAHA.113.004562
18. Anan F, Shimomura T, Kaku T, et al. High-sensitivity C-reactive protein level is a significant risk factor for silent cerebral infarction in patients on hemodialysis. Metabolism. 2008;57(1):66-70.
19. Sozio SM, Coresh J, Jaar BG, et al. Inflammatory markers and risk of cerebrovascular events in patients initiating dialysis. Clin J Am Soc Nephrol.2011;6(6):1292-300. doi: 10.2215/CJN.08350910
20. Tobian L. High-potassium diets markedly protect against stroke deaths and kidney disease in hypertensive rats, an echo from prehistoric days. J Hypertens Suppl. 1986;4(4):S67-76.
21. Tobian L, Lange JM, Johnson MA, et al. High-K diets reduce brain haemorrhage and infarcts, death rate and mesenteric arteriolar hypertrophy in stroke-prone spontaneously hypertensive rats. J Hypertens Suppl. 1986;4(5):S205-7.
22. Dorrance AM, Pollock DM, Romanko OP, Stepp DW. A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R415-22.
23. Çelik G, Doğan A, Dener Ş, Öztürk Ş, Kulaksızoğlu S, Ekmekçi H. Parathyroid Hormone Levels in the Prediction of Ischemic Stroke Risk. Dis Markers.2017;2017:4343171. doi: 10.1155/2017/4343171. doi: 10.1155/2017/4343171.
24. Korada SK, Zhao D, Gottesman RF, et al. Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study. J Stroke Cerebrovasc Dis. 2016;25(4):883-93. doi:10.1016/j.jstrokecerebrovasdis.2015.12.029.
25. Tagawa M, Hamano T, Nishi H, et al. Mineral Metabolism Markers Are Associated with Myocardial Infarction and Hemorrhagic Stroke but Not Ischemic Stroke in HemodialysisPatients: A Longitudinal Study. PLoS One. 2014;9(12):e114678. doi:10.1371/journal.pone.0114678. eCollection 2014.
26. Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol. 2007;292(4):F1215-8.
27. Hagström E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009;119(21):2765-71. doi:10.1161/CIRCULATIONAHA.108.808733
28. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68(4):1815-24.